<code id='82F498B6A3'></code><style id='82F498B6A3'></style>
    • <acronym id='82F498B6A3'></acronym>
      <center id='82F498B6A3'><center id='82F498B6A3'><tfoot id='82F498B6A3'></tfoot></center><abbr id='82F498B6A3'><dir id='82F498B6A3'><tfoot id='82F498B6A3'></tfoot><noframes id='82F498B6A3'>

    • <optgroup id='82F498B6A3'><strike id='82F498B6A3'><sup id='82F498B6A3'></sup></strike><code id='82F498B6A3'></code></optgroup>
        1. <b id='82F498B6A3'><label id='82F498B6A3'><select id='82F498B6A3'><dt id='82F498B6A3'><span id='82F498B6A3'></span></dt></select></label></b><u id='82F498B6A3'></u>
          <i id='82F498B6A3'><strike id='82F498B6A3'><tt id='82F498B6A3'><pre id='82F498B6A3'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:398
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Readout LOUD podcast: possible new ALS drug, artificial wombs
          Readout LOUD podcast: possible new ALS drug, artificial wombs

          CantheFDAbetooflexible?Howdoyoutestamechanicalwomb?Andwhodecideswhat’sgoodenoughforpatientsinneed?We

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          How AI helped researchers track recovery from depression

          AdobeResearcherssaythey’vebeenabletomeasurerecoveryfromtreatment-resistantdepressionthroughbrainscan